Tags
Anticoagulant, arthroplasty, deep vein thrombosis, England, Health, Hip Replacement, James Cook University Hospital, Lynda Williams, Medicine, science, surgery, Thrombosis
Arthroplasty wound complications linked to oral anticoagulant use.
Arthroplasty wound complications linked to oral anticoagulant use
Published on September 21, 2012 at 9:15 AM
By Lynda Williams, senior medwireNews Reporter
Multicenter research suggests that recovery from hip or knee arthroplasty may be significantly affected by choice of pharmaceutical thromboprophylaxis.
Pooled data from eight hospitals in England shows that patients given low molecular weight heparin (LMWH) had a significantly lower rate of wound complications in the 30 days after surgery than those treated with the oral anticoagulant rivaroxaban, at 2.81% versus 3.86% and an odds ratio (OR) of 0.72.
The rate of return to surgery to treat wound complications did not significantly differ by treatment, but patients with wound complications ‑ defined as hematoma or superficial or deep infection ‑ had a significantly longer stay on average than those without, at 14.2 versus 6.6 days.
However, patients given rivaroxaban were significantly less likely to develop symptomatic deep vein thrombosis than their LMWH-treated counterparts (0.23 vs 0.91%), report Simon Jameson (James Cook University Hospital, Middlesbrough, UK) and co-authors.
Source & full article – click here.
Related articles
- Thromboprophylaxis after joint replacement misses targets | Rheumatology Update (earlsview.com)
- Anti-clotting therapy may be used too often following orthopaedic surgery or trauma (eurekalert.org)
- One- Versus Two-stage Bilateral Total Hip Arthroplasty | Orthopedics (earlsview.com)
- Ion levels poor indicator for hip arthroplasty debris (earlsview.com)
- Revision of hip resurfacing arthroplasty with a bone-conserving short-stem implant (earlsview.com)
- Clemson Knee Simulator to Help Improve Unicompartmental Knee Arthroplasty (earlsview.com)
- Instability after total hip arthroplasty (earlsview.com)
- The Health Benefits of Nattokinase (naturalhealthezine.com)
- Omission of aspirin from antiplatelet regimen: The WOEST study (medicalxpress.com)
- Beyond Medication: Treatments for Blood Clots (everydayhealth.com)
Pingback: Re: Mortality and implant revision rates of hip arthroplasty in patients with osteoarthritis: registry based cohort study | BMJ « Earl's View